Retrograde transport and transcytosis of botulinum toxin serotypes to the brain: Analysis of potential neurotoxicity

Journal of Drugs in Dermatology

Volumn 7, Issue 10, 2008, Pages 1006-1007

  Alexiades Armenakas, Macrene ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN;

ANIMAL; BRAIN; FACE MUSCLE; HUMAN; INJECTION; METABOLISM; NERVE CELL; NOTE; PATHOLOGY; PHYSIOLOGY; RAT; TOXICITY AND INTOXICATION;

ANIMALS; BOTULINUM TOXINS; BRAIN; FACIAL MUSCLES; HUMANS; INJECTIONS; NEURONS; NEUROTOXICITY SYNDROMES; RATS;

EID: 59049105489     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (8)

1. Keller JE, Cai, F, Neale EA. Uptake of botulinum neurotoxin into cultured neurons. Biochemistry. 2004;43(2):526-532. (Pubitemid 38082576)
2. Vaidyanathan VV, Yoshino K, Jahnz M, et al. Proteolysis of SNAP-25 isoforms by botulinum neurotoxin types A, C, and E: domains and amino acid residues controlling the formation of enzyme-substrate complexes and cleavage. J Neurochem. 1999;72(1):327-337. (Pubitemid 29013908)
3. Keller, J. E., Neale, E. A. Oyler, G., and Adler, M. (1999) FEBS Lett. 456, 137-142.
4. Keller JE, Neale EA. The role of the synaptic protein snap-25 in the potency of botulinum neurotoxin type A. J Biol Chem. 2001 Apr 20;276(16):13476-82. Epub 2001 Jan 23.
5. Antonucci F, Rossi C, Gianfranceschi L, et al. Long-distance retrograde effects of botulinum neurotoxin A. J Neurosci. 2008 Apr 2;28(14):3689-96
6. Williamson et al.: Mol Biol Cell 6:61a, 1995;
7. J Biol Chem 271:7694-7699, 1996.
8. Williamson LC, Neale EA. Syntaxin and 25-kDa synaptosomal-associated protein: differential effects of botulinum neurotoxins C1 and A on neuronal survival. J Neurosci Res. 1998 Jun 1;52(5):569-583. (Pubitemid 28252738)